Chemed Q3 2024 Adj. EPS $5.64 Misses $5.76 Estimate, Sales $606.181M Miss $612.215M Estimate
Portfolio Pulse from Benzinga Newsdesk
Chemed's Q3 2024 earnings and sales missed analyst estimates, with EPS at $5.64 versus the expected $5.76 and sales at $606.181M versus the expected $612.215M. Despite the miss, sales increased by 7.38% compared to the same period last year.
October 29, 2024 | 8:25 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Chemed's Q3 2024 earnings and sales missed analyst expectations, with EPS at $5.64 and sales at $606.181M. Despite the miss, sales increased by 7.38% year-over-year.
Chemed's earnings and sales both missed analyst estimates, which is likely to negatively impact the stock price in the short term. However, the year-over-year sales growth of 7.38% may mitigate some of the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100